Publiziert in: Marktpuls, Unternehmen
Frei

Genentech : FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications Montag, 12. April 2021 - 19:58

Genentech News Subscription Service



If you would like to contact Genentech, we can be reached at:

Genentech
1 DNA Way
South San FranciscoCA 94080

Add us to your address book

Copyright (C) 2021 Genentech All rights reserved.